A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/325 (2006.01) A61K 31/357 (2006.01) A61K 31/396 (2006.01) A61K 31/40 (2006.01) A61K 31/4025 (2006.01) A61K 31/403 (2006.01) A61K 31/4155 (2006.01) A61K 31/4178 (2006.01) A61K 31/4192 (2006.01) A61K 31/4245 (2006.01) A61K 31/427 (2006.01) A61K 31/428 (2006.01) A61K 31/4433 (2006.01) A61K 31/4439 (2006.01) A61K 31/453 (2006.01)
Patent
CA 2731685
A method of treating a glomerular disease selected from the group consisting of mesangial proliferative glomeru-lonephritis, collapsing glomerulopathy, proliferative lupus nephritis, crescentic glomerulonephritis and membranous nephropathy in a subject comprises administering to the subject an effective amount of a glucosylceramide synthase inhibitor.
L'invention concerne un procédé de traitement d'une maladie glomérulaire sélectionnée dans le groupe comprenant une glomérulonéphrite membranoproliférative, une glomérulopathie avec collapsus, une néphrite lupique proliférative, une glomérulonéphrite extracapillaire, et une néphropathie membraneuse chez un sujet, comprenant l'administration au sujet d'une quantité efficace d'un inhibiteur de synthase de glucosylcéramide.
Ibraghimov-Beskrovnaya Oxana
Natoli Thomas A.
Genzyme Corporation
Gowling Lafleur Henderson Llp
LandOfFree
Glucosylceramide synthase inhibition for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glucosylceramide synthase inhibition for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glucosylceramide synthase inhibition for the treatment of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1904905